Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Gimme Care vs AVARA Rx

Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, AVARA Rx a 65. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Gimme Care

#5 · Grade A · Best Value

Est. first month

$130/mo

Save ~90% vs brand-name
Get this deal Full Gimme Care review →
VS

AVARA Rx

#312 · Grade C · Watch List

Est. first month

From $229/mo (starting dose, compounded)

Save ~83% vs brand-name
Get this deal Full AVARA Rx review →

The verdict

Better value: Gimme Care

Gimme Care takes it on Value Score, 91 to 65 an est. $130/mo first month, with no teaser step-up baked in. AVARA Rx isn't out of it: Shoppers who want 50-state compounded GLP-1 with named pharmacy and clinical network.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealGimme CareAVARA Rx
Value Score91 (A)65 (C)
Est. first month$130/moFrom $229/mo (starting dose, compounded)
Save vs brand-name~90%~83%
Semaglutide$130/moFrom $229/mo (starting dose, compounded)
Tirzepatide$163/moFrom $279/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

93
Lowest Real Price
66
Gimme Care: 93. AVARA Rx: 66.
88
No Teaser-Rate Bait
30
Gimme Care: 88. AVARA Rx: 30.
98
Nationwide Availability
96
Gimme Care: 98. AVARA Rx: 96.
92
Both Molecules
92
Gimme Care: 92. AVARA Rx: 92.
84
Easy Cancellation
58
Gimme Care: 84. AVARA Rx: 58.
82
Reputation
73
Gimme Care: 82. AVARA Rx: 73.

Gimme Care

Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.

Why it's a deal

  • Low flat price on both molecules ($130 sema / $163 tirz)
  • LegitScript-certified pharmacy
  • Available in all 50 states

The fine print

  • No brand-name option — compounded only
  • No oral/sublingual form

AVARA Rx

AVARA Rx is a nationwide DTC telehealth platform offering compounded semaglutide and tirzepatide plus brand-name Wegovy, Zepbound, and Foundayo consultations, alongside HRT, TRT, and longevity add-ons.

Why it's a deal

  • Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
  • Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
  • All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
  • Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
  • LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities

The fine print

  • Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
  • Dose pricing not itemized — only 'starting at $229' semaglutide and 'starting at $279' tirzepatide
  • LegitScript certification number not shown — badge only, so no direct lookup
  • No named medical director (Beluga Health is the network, not a named MD)
  • Lab work requirements not specified, and consultation fee not broken out from medication cost
Get the Gimme Care deal Get the AVARA Rx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to AVARA Rx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.